In recent years, the R&D budget for Health and Society in Mexico, measured as a percentage of GDP, has experienced a noticeable decline. Starting at 0.028% in 2013, this figure dropped progressively to 0.019% by 2023. The most significant dip occurred between 2017 and 2019, reflecting decreasing support for R&D relative to GDP. The year-on-year variation shows sporadic changes, with a remarkable decline in 2017 and subsequent minor fluctuations. The compound annual growth rate (CAGR) over the past five years indicates a general downward trend, albeit with a slight positive shift in 2023. From 2024 onward, forecasts suggest a stabilization around 0.021%, indicating potential recovery albeit at a subdued rate with a forecasted 5-year CAGR of 0.44%.
Looking forward, key trends to watch include the impact of policy shifts and governmental prioritization of health R&D, responses to global health challenges, and economic factors affecting GDP share allocation. Monitoring these will be critical in understanding future budget trajectories and associated societal impacts.
